A "futile cycle" induced by thiazolidinediones in human adipose tissue?

被引：28

作者：

Tan, GD

Debard, C

Tiraby, C

Humphreys, SM

Frayn, KN

Langin, D

Vidal, H

Karpe, F

机构：

[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford OX3 7LJ, England

[2] Univ Lyon 1, INSERM, U449, R Laennec Fac Med, F-69372 Lyon 08, France

[3] Univ Toulouse 3, Unite Rech Obes, INSERM, U586,Inst Louis Bugnard,Ctr Hosp Univ Toulouse, F-31403 Toulouse 4, France

来源：

NATURE MEDICINE | 2003年 / 9卷 / 07期

关键词：

D O I：

10.1038/nm0703-811

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：811 / 812

页数：2

共 10 条

[1] Systemic and regional free fatty acid metabolism in type 2 diabetes [J].

Basu, A ;

Basu, R ;

Shah, P ;

Vella, A ;

Rizza, RA ;

Jensen, MD .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (06) :E1000-E1006

[2]

CHAKRABARTY K, 1984, INT J OBESITY, V8, P609

[3] β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death [J].

Finegood, DT ;

McArthur, MD ;

Kojwang, D ;

Thomas, MJ ;

Topp, BG ;

Leonard, T ;

Buckingham, RE .

DIABETES, 2001, 50 (05) :1021-1029

[4]

Frayn KN, 2000, METH MOL B, V155, P269

[5] CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].

FUJIWARA, T ;

YOSHIOKA, S ;

YOSHIOKA, T ;

USHIYAMA, I ;

HORIKOSHI, H .

DIABETES, 1988, 37 (11) :1549-1558

[6] A futile metabolic cycle activated in adipocytes by antidiabetic agents [J].

Guan, HP ;

Li, Y ;

Jensen, MV ;

Newgard, CB ;

Steppan, CM ;

Lazar, MA .

NATURE MEDICINE, 2002, 8 (10) :1122-1128

[7]

Jensen MD, 2002, J ROY SOC MED, V95, P3

[8] Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus - A randomized, double-blind, placebo-controlled trial [J].

Maggs, DG ;

Buchanan, TA ;

Burant, CF ;

Cline, G ;

Gumbiner, B ;

Hsueh, WA ;

Inzucchi, S ;

Kelley, D ;

Nolan, J ;

Olefsky, JM ;

Polonsky, KS ;

Silver, D ;

Valiquett, TR ;

Shulman, GI .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :176-185

[9] Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients [J].

Miyazaki, Y ;

Glass, L ;

Triplitt, C ;

Matsuda, M ;

Cusi, K ;

Mahankali, A ;

Mahankali, S ;

Mandarino, LJ ;

DeFronzo, RA .

DIABETOLOGIA, 2001, 44 (12) :2210-2219

[10] Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus [J].

Racette, SB ;

Davis, AO ;

McGill, JB ;

Klein, S .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (02) :169-174

← 1 →